Exousia Pro Announces Strategic Elimination of Future Dilutive Issuance and Progresses Toward Telehealth Acquisitions
Exousia Pro, Inc. announces the cancellation of derivative securities convertible into 47 million shares of Common Stock and progresses toward definitive agreements for telehealth acquisitions.